António Travassos,
Susana Teixeira,
Pinto Ferreira,
Isaura Regadas, Ana Sofia Travassos,
Florindo Esteves Esperancinha,
Isabel Prieto,
Grapa Pires,
Robert van Velze,
A Valido,
Maria do Céu Machado
[show abstract]
[hide abstract]
ABSTRACT: The anatomic response to intravitreal bevacizumab injection in three patients with aggressive, posterior retinopathy of prematurity is described. In all cases, the worse eye was treated with a single intravitreal injection of 0.75 mg of bevacizumab as monotherapy or complementary to laser therapy. In 24 hours, all injected eyes showed regression of the tunica vasculosa lentis and iris vessel engorgement and disappearance of iris rigidity. In addition, plus disease and retinal proliferation began to regress. None of the eyes required additional treatment. Follow-up of up to 10 months
Ophthalmic Surgery Lasers and Imaging 38(3):233-7. · 0.62 Impact Factor
